Safety

NutraCast: Safety considerations for dietary supplement manufacturers

16-Feb-2024 By Danielle Masterson

A new paper is out titled “Safety Considerations for Dietary Supplement Manufacturers in the United States", co-authored by Jay Sirois, PhD, VP of regulatory and scientific affairs, Consumer Healthcare Products Association, alongside several CHPA...

New tox study validates safe upper dose for cbdMD’s Broad Spectrum CBD blend

25-Sep-2023 By Stephen Daniells

cbdMD's proprietary broad spectrum blend is safe when consumed as a dietary supplement in doses up to 160 mg per day in a 70 kg (154 lb), says a new study published in Regulatory Toxicology and Pharmacology.

Charlotte’s Web-Canopy Growth analysis identifies safe CBD intake levels for supplements

18-Sep-2023 By Claudia Adrien

Upper CBD intake levels ranging from 70 mg to 160 mg per day for dietary supplements are acceptable and do not harm the liver, says a new scientific review commissioned by Canopy Growth Corporation and Charlotte’s Web.

Stakeholders go to bat over controversial ingredient titanium dioxide

13-Sep-2023 By Danielle Masterson

Less than a year ago, FDA told FoodNavigator-USA that it considers TiO2 to be safe, citing available studies that do not demonstrate safety concerns connected to the use of TiO2 as a color additive.

cbdMD CSO: ‘It appears that we’re finally making headway in Congress’

22-Aug-2023 By Stephen Daniells

The recent congressional hearing about CBD and subsequent ‘historic’ bicameral Request for Information (RFI) shows that hemp-derived CBD for use in dietary supplements has finally got the attention of Congress, said cbdMD’s CSO.

Accreditation board aims to enhance scientific credibility of supplements

19-May-2023 By Olivia Haslam

A nonprofit accreditation body, Empowered by Evidence (EBE), gave an impassioned presentation to the audience of Vitafoods 2023, calling for companies to promote better standards in industry science.

Wake up call or false alarm? New JAMA paper reports problems with melatonin gummies

26-Apr-2023 By Danielle Masterson

Over 85% of melatonin gummy products tested in a new analysis found that the supplements did not contain the levels of melatonin listed on the label, according to researchers at the University of Mississippi and the Cambridge Health Alliance. Industry...

Study shows safety and health benefits of coffee cherry pulp juice

29-Mar-2023 By Asia Sherman

A new study from researchers in Thailand supports the safety of coffee cherry pulp juice consumption and suggests that it may lower cholesterol in healthy adults.

Safety pioneer named NutraChampion, talks analyzing adverse events data

25-Jul-2022 By Danielle Masterson

This year’s NutraIngredients-USA NutraChampion, Rick Kingston, PharmD, presented at the Dietary Supplement Regulatory Summit. The one day event included the five heavy hitters representing the industry: Consumer Healthcare Products Association (CHPA),...

CBD safety: Large-scale study finds no evidence of liver toxicity from oral CBD products

23-Mar-2021 By Stephen Daniells

Colorado-based ValidCare has announced the preliminary findings from its industry-sponsored, decentralized human safety study of hemp derived CBD products, with the data indicating no liver toxicity.

Study supports safety and efficacy of enXtra caffeine alternative

24-Jul-2020 By Stephen Daniells

Consumption of enXtra, a caffeine-free energy ingredient derived from Alpinia galanga, can boost alertness and calmness scores, says a new study that also supports the long-term safety of the ingredient.

Post-market surveillance supports safety and tolerability of PlusCBD products

27-May-2020 By Stephen Daniells

Data collected over two years of post-market surveillance offers strong support for the safety and tolerability of PlusCBD products from CV Sciences, with fewer than 0.03% of products producing any kind of adverse event.

Safety review backs natural astaxanthin, but holds off on synthetic forms

06-Dec-2019 By Hank Schultz

A recent review of astaxanthin found evidence to support the safety of dosages of 12 mg up to 24 mg a day. But that applies to only to natural astaxanthin, not to the synthetic forms, the authors said.

CRN takes issue with how Pew reported adverse event finding in recent supplement survey

02-Oct-2019 By Hank Schultz

A new Pew survey on dietary supplements found that 1 in 8 consumers said they or a family member had experienced an adverse event, a finding which has been criticized as a faulty statistic.

Setting the record straight: Botanical Safety Consortium not involved in regulatory decisions, says co-chair

29-May-2019 By Adi Menayang

The main purpose of the Botanical Safety Consortium, a public-private effort bringing together stakeholders in the botanical supplements space, is “advancing the science of botanical safety evaluation, [and is] not involved in regulatory decisions or...